REPS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.63136171238421E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.5087000001316E-08 |
Normal-vs-Stage2 |
6.25249999997024E-07 |
Normal-vs-Stage3 |
1.82887038846502E-12 |
Normal-vs-Stage4 |
2.59636756538839E-12 |
Stage1-vs-Stage2 |
2.353600E-02 |
Stage1-vs-Stage3 |
4.369600E-04 |
Stage1-vs-Stage4 |
2.431100E-04 |
Stage2-vs-Stage3 |
7.585000E-01 |
Stage2-vs-Stage4 |
4.794200E-01 |
Stage3-vs-Stage4 |
6.035800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.99840144432528E-15 |
Normal-vs-AfricanAmerican |
5.603600E-04 |
Normal-vs-Asian |
3.829400E-01 |
Caucasian-vs-AfricanAmerican |
2.287200E-01 |
Caucasian-vs-Asian |
4.113600E-01 |
AfricanAmerican-vs-Asian |
7.490600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
2.12230000018465E-07 |
Male-vs-Female |
3.741000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.212000E-04 |
Normal-vs-Age(41-60Yrs) |
6.27170537725874E-11 |
Normal-vs-Age(61-80Yrs) |
1.06370467989336E-12 |
Normal-vs-Age(81-100Yrs) |
1.404350E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.191400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.255200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.680800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.961000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.755600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.352800E-01 |
Normal-vs-Grade 2 |
1.00179999995564E-06 |
Normal-vs-Grade 3 |
1.62447832963153E-12 |
Normal-vs-Grade 4 |
2.08919548327913E-11 |
Grade 1-vs-Grade 2 |
4.676500E-02 |
Grade 1-vs-Grade 3 |
2.837700E-04 |
Grade 1-vs-Grade 4 |
3.577000E-04 |
Grade 2-vs-Grade 3 |
4.06040000000552E-06 |
Grade 2-vs-Grade 4 |
4.12040000000724E-05 |
Grade 3-vs-Grade 4 |
3.218200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.44339999999821E-05 |
Normal-vs-ccB subtype |
1.62547753035369E-12 |
ccA subtype-vs-ccB subtype |
2.70830000004274E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.75699463259116E-11 |
Normal-vs-N1 |
1.565080E-04 |
N0-vs-N1 |
1.906490E-02 |
|
|